• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 4. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyrimidines Purines and purine derivatives 6-thiopurines

Comprehensive Overview of 6-(Propylsulfanyl)-9H-Purine (CAS No. 6288-93-3): Properties, Applications, and Research Insights

6-(Propylsulfanyl)-9H-purine (CAS No. 6288-93-3) is a specialized purine derivative that has garnered significant attention in pharmaceutical and biochemical research due to its unique structural and functional properties. This compound, characterized by a propylsulfanyl moiety attached to the purine core, serves as a versatile intermediate in the synthesis of bioactive molecules. Researchers and industry professionals frequently search for terms like "purine derivatives applications", "sulfur-containing purine synthesis", and "CAS 6288-93-3 uses", reflecting its relevance in drug discovery and molecular design.

The growing interest in 6-(propylsulfanyl)-9H-purine aligns with broader trends in medicinal chemistry and biocatalysis. As the demand for targeted therapies and small-molecule inhibitors rises, this compound's role in modulating enzymatic activity and cellular pathways becomes increasingly critical. Recent studies highlight its potential in kinase inhibition and nucleic acid interactions, addressing common search queries such as "how does sulfur modification affect purine activity?" and "purine-based drug candidates 2024".

From a structural perspective, the propylsulfanyl group enhances the compound's lipophilicity, influencing its bioavailability and membrane permeability—key factors discussed in forums on ADME optimization. Analytical techniques like HPLC and NMR spectroscopy are typically employed to characterize CAS No. 6288-93-3, as evidenced by frequent searches for "purine derivative characterization methods". Environmental and safety assessments confirm its stability under standard laboratory conditions, though proper handling protocols remain essential.

Innovations in green chemistry have also impacted the synthesis of 6-(propylsulfanyl)-9H-purine, with researchers exploring catalyst-free reactions and solvent-free conditions to improve sustainability. These advancements respond to trending topics like "eco-friendly heterocyclic compound synthesis" and "reducing waste in pharmaceutical intermediates". Furthermore, computational modeling studies predict its binding affinities for various biological targets, making it a subject of AI-driven drug discovery initiatives.

In conclusion, 6-(propylsulfanyl)-9H-purine (CAS No. 6288-93-3) represents a compelling case study at the intersection of traditional organic chemistry and cutting-edge biomedical research. Its applications span from preclinical drug development to material science, addressing persistent challenges in selective functionalization and structure-activity relationships. As scientific databases and patent filings expand, this compound continues to inspire queries like "latest patents on modified purines" and "emerging purine analogs in oncology", cementing its role in next-generation therapeutics.

• 5069-82-9(6-(Butylthio)-purine)
• 5443-88-9(6-(prop-2-en-1-ylsulfanyl)-9H-purine)
• 5417-84-5(6-Ethylmercaptopurine)
• 83277-80-9(6-n-Heptylmercaptopurine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)